The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Biomarkers in Rheumatoid Arthritis Remain Elusive

Biomarkers in Rheumatoid Arthritis Remain Elusive

February 1, 2015 • By Kathy Holliman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

According to Dr. Rigby, the greatest application of Vectra is for predicting people with poor outcomes or for predicting that a patient is in low disease activity even when they are still reporting lots of symptoms. The big question in a patient with painful hands but no swelling is whether the patient’s “amplification of pain pathways is talking or whether it is the synovial inflammation talking. Some say Vectra is very good at that. Others would say why not do musculoskeletal ultrasound of that particular joint and confirm the inflammation.”

You Might Also Like
  • Letters: Biomarkers for Rheumatoid Arthritis
  • Progress Slow in Development of Useful Biomarkers for Rheumatoid Arthritis Treatment
  • Rheumatoid Arthritis Patients on Biologics Remain At Risk of Infection
Explore This Issue
February 2015
Also By This Author
  • Cardiovascular Risk in Tocilizumab Therapy for RA

But of course the problem remains that, even if it is the inflammation talking, there is still no biomarker that can predict the best treatment for the patient whose disease does not respond adequately to methotrexate or even triple therapy.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The search for the holy grail in RA is a complex one, but one worth doing, Dr. Kremer says. “The stakes are so high. People are suffering with a chronic lifelong disease, and these interventions are very expensive. In fact, the Corrona data show that 55–60% of all RA patients in the U.S. are on some type of biologic drug. In an era of shrinking resources for these expensive drugs, it would save society a lot of money if individuals can be identified up front as better or worse candidates for a particular intervention.”


Kathy Holliman is a medical journalist based in Beverly, Mass.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Robinson WH, Lindstrom TM, Cheung RK, Sokolove J. Mechanistic biomarkers for clinical decision making in rheumatic diseases. Nat Rev Rheumatol. 2013;9:267–276.
  2. Dennis G Jr., Holweg CTJ, Kummerfield SK, et al. Arthritis Res Ther. 2014;16:R90;1–18.
  3. Snyder A, Makarov V, Merghoub T, et al. Genetic basis for clinical response to CTLA-4 blockade in Melanoma. N Engl J Med. 2014. Doi:10.1056/NEJMoa1406498.

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Biomarkers, Holliman, Rheumatoid arthritisIssue: February 2015

You Might Also Like:
  • Letters: Biomarkers for Rheumatoid Arthritis
  • Progress Slow in Development of Useful Biomarkers for Rheumatoid Arthritis Treatment
  • Rheumatoid Arthritis Patients on Biologics Remain At Risk of Infection
  • Cure, Effective Treatment for Lupus Nephritis Remain Elusive Despite Advances

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.